
KLOW 80MG
No COA is linked to this product yet. Check the COA page or contact support if a document should be available.
Open COA pageSelect your amount and quantity.
KLOW 80MG Research Overview
KLOW is an 80 mg four-peptide research blend combining GHK-Cu, BPC-157, TB-500 and KPV — copper-peptide, tissue-remodeling and anti-inflammatory signaling peptides in one vial. KLOW 80MG is supplied for qualified in-vitro laboratory research and analytical use only.
Compound profile
- Compound class: Four-peptide research blend
- Components: GHK-Cu, BPC-157, TB-500 (thymosin beta-4 fragment) and KPV
- Total: 80 mg per vial
- Form: Lyophilized multi-peptide blend in a sealed vial
- Testing: Third-party HPLC purity and identity, batch-matched COA
Research context
The combination supports research that examines matrix biology (GHK-Cu), angiogenesis and gut-barrier models (BPC-157), actin-mediated cell migration (TB-500) and NF-κB-related inflammatory signaling (KPV) together. Each component is also stocked separately for single-compound controls, and the batch COA lists the blend composition.
Storage and handling
Store unopened lyophilized vials sealed and protected from light — at −20 °C for long-term storage, or 2–8 °C for short-term use. Once reconstituted, keep refrigerated at 2–8 °C, minimize freeze–thaw cycles and rely on your laboratory’s own validated stability data.
Quality and documentation
Every lot is third-party tested, and the Certificate of Analysis is matched to the exact batch you receive — look it up any time on the COA page. Browse more Research Blends, or see related compounds: GLOW 70MG, GHK-CU, KPV 10MG.
Research Use Only Notice: Not for human consumption, not for veterinary use, not for clinical or diagnostic use, and not intended as a drug, food, dietary supplement, cosmetic, or household product. Purchaser is responsible for confirming lawful use, handling requirements, and regulatory status before purchase or use.